News Hub

Jun 1, 2026

Avery Klein

Press Releases

Celcuity to Hold Conference Call to Discuss Results for the PIK3CA Mutant Cohort of the Phase 3 VIKTORIA-1 Clinical Trial of Gedatolisib Regimens in HR+/HER- Advanced Breast Cancer on June 2, 2026

Celcuity Inc., a clinical-stage biotech company, announced a conference call on June 2, 2026, to discuss results from the PIK3CA mutant cohort of its Phase 3 VIKTORIA-1 clinical trial. This trial evaluates Gedatolisib, a novel PI3K/mTOR inhibitor, in combination regimens for treating hormone receptor positive, HER2-negative advanced breast cancer. …

CELC

Jun 1, 2026

Derek Hwang

Insider Trading

Director Thomas Kirk Acquires Myomo Stock Amid Strong Momentum and Earnings Beat

MYOMO, INC. (MYO) director Thomas F. Kirk recently purchased a significant block of the company's common stock via open market purchases, according to a recent SEC filing. This transaction occurred on May 28, 2026. The purchase comes as Myomo continues to show strong momentum, having delivered a 22% return over the past three months, and following …

Jun 1, 2026

Nina Shah

Stock Markets

Morgan Stanley reverses stance on Dell, more than doubles price objective

Morgan Stanley upgraded Dell Technologies to Equal-weight from Underweight and raised its price target to $448 from $170 after concluding the company is navigating the semiconductor supply shortage more effectively than peers. The change follows Dell's first-quarter results and a research trip to Taiwan, prompting the bank to boost its fiscal 2027 …

Jun 1, 2026

Ajmal Hussain

Stock Markets

Strategy Inc. Stock Drops After Disclosure of Small Bitcoin Sale; Company Reaffirms Dividend Plans

Shares of Strategy Inc (NASDAQ:MSTR) declined 4.7% on Monday following an SEC filing that disclosed the sale of 32 bitcoin last week and additional equity sales under an at-the-market program. The filing detailed the bitcoin sale proceeds and reaffirmed the companys sizeable bitcoin position, outstanding issuance capacity, declared preferred divid…

Jun 1, 2026

Sofia Navarro

Press Releases

Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657

Cosmos Health Inc. (NASDAQ:COSM) announced its entry into the global animal health sector by launching a veterinary formulation of its antimicrobial product C-Scrub Wash 4%. The product has passed stringent European veterinary disinfectant standards (EN 1656 and EN 1657) and is set to launch first in the UK, with plans for international expansion. …

COSM

Jun 1, 2026

Jordan Park

Trade Ideas

Life360: Ads, Buybacks and Strong FCF Make a Tactical Long at $43.69

Life360 accelerated monetization in Q1 2026—38% revenue growth, a quadrupling ad business to $19.7M after the Nativo acquisition, and a $225M buyback authorization. The combination of subscription momentum, ad expansion, positive free cash flow, and a conservative balance sheet supports a tactical long. Trade plan: enter at $43.69, stop $38.00, tar…

LIF

Jun 1, 2026

Hana Yamamoto

Stock Markets

Motorola Expands Counter-Drone Capabilities with $1.5 Billion D-Fend Acquisition

Motorola Solutions has agreed to acquire Israeli start-up D-Fend Solutions for $1.5 billion, acquiring radio-wave based drone-takeover technology to address growing threats from rogue drones. The purchase, expected to close in the fourth quarter of 2026, complements Motorola's earlier Silvus acquisition and taps a rising market driven by new U.S. l…

Jun 1, 2026

Priya Menon

Economy

IMF Endorses Brazil's Recent Rate Reductions but Urges Caution Amid Uncertainty

The International Monetary Fund said Brazil’s central bank acted appropriately in cutting policy rates in March and April, while urging continued flexibility in future decisions because of elevated uncertainty and renewed inflation pressures tied to high global energy prices. The IMF also noted the economy's resilience through recent shocks and pro…

Jun 1, 2026

Hana Yamamoto

Press Releases

Jiuzi Holdings Announces AI Intelligent Imaging Platform Achieves Milestone Progress and Advances Toward Commercial Deployment as Planned

Jiuzi Holdings announced significant progress in developing its AI intelligent imaging and data platform, moving forward with plans for commercial deployment. The platform integrates AI recognition, data processing, and cloud architecture to provide scalable, real-time analytics solutions designed for enterprise clients. Key features include facial…

JZXN

Jun 1, 2026

Priya Menon

Press Releases

Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026

Greenwich LifeSciences reports promising open-label data from their Phase III FLAMINGO-01 clinical trial evaluating GLSI-100, an immunotherapy designed to prevent breast cancer recurrences. Preliminary results show a statistically significant increase in injection site immune reactions after multiple vaccinations in a non-HLA-A*02 patient arm, supp…

GLSI

Jun 1, 2026

Nina Shah

Press Releases

Osisko Development Announces Closings of Additional US$75 Million Aggregate Principal Amount of 4.125% Convertible Senior Notes Bringing Total Offering to US$300 Million

Osisko Development Corp. has completed a US$300 million offering of 4.125% convertible senior notes due 2031, including the full exercise of initial purchaser options and a private placement with Double Zero Capital. The proceeds, net of costs for capped call transactions to mitigate dilution, will fund the development and pre-construction activiti…

ODV

Jun 1, 2026

Jordan Park

Trade Ideas

Magnachip (MX): A Coiled-Spring Momentum Trade Into AI-Driven Power Demand

Magnachip has rallied from a $2.18 low to test a $9.67 52-week high after a Q1 that beat revenue estimates. The company’s MOSFETs, PMICs and power-management lineup give it asymmetric upside if AI and computing customers accelerate design wins. With a modest market cap (~$320M), clean balance-sheet ratios and an EV/Sales of ~1.5, this is a swing tr…

MX

Jun 1, 2026

Ajmal Hussain

Stock Markets

MGM Resorts Shares Jump After Report of $18 Billion Takeover Proposal from People Inc.

MGM Resorts International stock climbed about 10% Monday after reports that Barry Diller's People Inc., formerly IAC, is preparing an $18 billion all-cash takeover proposal. The reported offer would value the remaining 73.9% of MGM not owned by People Inc. at $48.30 per share, a 10.6% premium to the prior close. People Inc. already holds a 26.1% st…

Jun 1, 2026

Nina Shah

Stock Markets

Texas Capital Lowers Rating on Caesars to Hold, Cites $31 Buyout as Cap on Upside

Texas Capital reduced its recommendation on Caesars Entertainment to Hold after Fertitta Entertainment agreed to acquire the company for $31 per share. The firm says the offer - which values Caesars at about 7x 2027 EV/EBITDA and roughly $17.6 billion in total - limits upside for public shareholders even though Caesars' operations and cash generati…

Jun 1, 2026

Derek Hwang

Economy

Bank of England flags public-sector pay as an inflation risk amid widening wage gap

The Bank of England is increasing scrutiny of public-sector pay after it has outpaced private-sector wages for a year, Governor Andrew Bailey said. With public pay excluding bonuses rising more quickly on an annual basis for 12 consecutive months - the longest such streak since 2021 and before that 2011 - the central bank is concerned that a wideni…

Jun 1, 2026

Nina Shah

Press Releases

Alpha Cash Cardholders To Get $2.50 Back Monthly on Certain Transit in 11 U.S. Cities

Alpha Modus Holdings announces that holders of its Alpha Cash Prepaid Mastercard will receive a $2.50 monthly rebate when spending $10 or more on public transit across 11 major U.S. metropolitan areas via Mastercard's Public Transit Benefit. This program targets unbanked and underbanked consumers, offering them rewards previously unavailable throug…

AMOD

Jun 1, 2026

Derek Hwang

Economy

UBS Flags Greater-than-Expected ECB Tightening Risk Despite June Hike Seen as Certain

UBS expects the European Central Bank to lift its main rate by 25 basis points to 2.25% at the June 11 meeting, a move largely priced in by markets. The bank, however, cautions that investors may be underestimating the probability of further tightening through the remainder of the year and flags upside risk to its own forecast of two small hikes.

Jun 1, 2026

Maya Rios

Press Releases

LifeMD Appoints Umesh Sripad as Chief Technology Officer

LifeMD, a Nasdaq-listed telehealth company, announced the immediate appointment of Umesh Sripad as Chief Technology Officer. Mr. Sripad brings over 20 years of experience in digital transformation and technology leadership from major consumer and healthcare-related companies. His role will focus on leading LifeMD's technology strategy, platform tra…

LFMD

Jun 1, 2026

Priya Menon

Stock Markets

EU Draft Cloud Rules Could Bar U.S. Tech Firms from Sensitive State Contracts

A draft European Commission proposal under the Cloud and AI Development Act would impose strict eligibility conditions for cloud services used in highly critical government tenders. The measures, which EU tech chief Henna Virkkunen is set to present on Wednesday as part of a broader tech sovereignty package, include mandatory non-price award criter…

Jun 1, 2026

Marcus Reed

Stock Markets

U.S. Futures Rise as Nvidia Unveils New PC Processor; Biotech Winners, Redwire Slips

U.S. equity futures moved higher Monday morning as optimism around artificial intelligence was reinforced by Nvidia's launch of a new high-end processor for Windows PCs. The advance in futures followed gains at the end of last week, even as fresh strikes in the Middle East dimmed prospects for a near-term ceasefire agreement between the U.S. and Ir…

Jun 1, 2026

Maya Rios

Press Releases

MBX Biosciences to Host Virtual Investor Event to Discuss Once-Weekly Canvuparatide Presentations at ENDO 2026

MBX Biosciences announced it will present new Phase 2 and one-year extension data on its once-weekly canvuparatide treatment for chronic hypoparathyroidism at the Endocrine Society's Annual Meeting (ENDO 2026). The company will also host an investor webcast to discuss the clinical trial results, highlighting progress toward Phase 3 development.

MBX

Jun 1, 2026

Marcus Reed

Press Releases

NuCana Appoints Ian Webster as Chief Financial Officer

NuCana plc, a clinical-stage biopharmaceutical company focused on cancer treatments, has appointed Ian Webster as Chief Financial Officer. Webster, formerly Interim CFO and Director of Finance, brings extensive financial and biopharmaceutical sector experience. His appointment comes as NuCana advances its Phase 2 clinical studies for NUC-7738 and N…

NCNA

Jun 1, 2026

Jordan Park

Press Releases

Nasus Pharma to Host Virtual KOL Event on June 10, 2026 to Discuss NS002 for the Treatment of Anaphylaxis

Nasus Pharma announces a virtual key opinion leader event on June 10, 2026, to present NS002, its intranasal epinephrine powder for anaphylaxis treatment, featuring expert discussion of Phase 2 data showing faster and higher absorption compared to EpiPen. The event aims to showcase NS002's potential as a needle-free alternative addressing unmet med…

NSRX

Jun 1, 2026

Caleb Monroe

Press Releases

Aprea Therapeutics Presents Updated Phase 1 Data on WEE1 Inhibitor APR-1051 at ASCO 2026, Demonstrating Early Monotherapy Activity and Manageable Tolerability in Advanced Solid Tumors

Aprea Therapeutics presented updated Phase 1 clinical trial data for their oral WEE1 inhibitor, APR-1051, at ASCO 2026. The data demonstrated preliminary anti-tumor activity, including partial responses and stable disease in heavily pretreated patients with advanced solid tumors, along with a favorable safety and tolerability profile. Enrollment is…

APRE

Jun 1, 2026

Caleb Monroe

Press Releases

Spectral AI Announces Voting Results of Annual Meeting of Stockholders

Spectral AI, Inc. announced the results of its 2026 Annual Meeting confirming all shareholder proposals, including board elections and audit firm ratification. The company highlighted its receipt of FDA De Novo classification for the DeepView System, enabling commercial distribution in the U.S. It also secured $31.7 million funding from BARDA, expa…

MDAI